Corbus Readies Pivotal Phase 3 Trial of Anabasum, Possible Scleroderma Treatment

20Dec

Corbus Readies Pivotal Phase 3 Trial of Anabasum, Possible Scleroderma Treatment

Portfolio News

Corbus Pharmaceuticals is planning a global Phase 3 trial to assess anabasum (JBT-101) as a treatment for scleroderma. If successful, the company plans to apply to regulatory authorities, asking that anabasum be the first specifically approved treatment for scleroderma. Read more >>

Share this post

Related Posts

10Jun

Myomo, Inc. Completes Historic Initial Public Offering

Myomo, Inc., a commercial stage medical robotics company, today announced the completion of its initial public offering (IPO) under SEC... read more
21Mar

Wasabi CFO On Doing Business With SVB: What Worked, What Didn’t And What’s Ahead

Silicon Valley Bank: The Right Bank, But Wasabi Ready To Move On. The surprise demise of Silicon Valley Bank (SVB)... read more
09Jun

Platelet Biogenesis Raises a $10 Million Series A Financing Led by Qiming U.S. Healthcare Fund

Platelet BioGenesis, a biotech startup developing a process to produce life-saving human platelets from stem cells for therapeutic applications, announced... read more
04Jun

Boulder Clean introduces laundry detergent with new packaging

"Plant-based cleaning products company Boulder Clean has partnered with thermoplastics polyolefins producer Braskem to revamp the packaging of its laundry... read more
13Sep

LaunchPad Medical Received FDA Approval to Initiate a Clinical Study

LaunchPad Medical, Inc. has received approval from the U.S. Food and Drug Administration to initiate a two-site, 20-patient pilot clinical... read more
07Nov

Shark Tank’ appearance sparks success for Massachusetts company creating greener world through chemistry

Framingham’s DetraPel is trying to create a greener world with chemistry. Overlooking 23,000 square feet of manufacturing space, David Zamarin’s... read more
25Jan

Guilford Community Response Gives Alex ESight

In less than one week's time, an overwhelming response from Guilford community members has generated some $6,500 to help 16... read more
19Feb

These high-tech glasses let the legally blind see

eSight is releasing a new product on Tuesday that helps blind people see. The glasses, which look similar to a... read more
04Mar

See That Smile

Forget virtual reality; Christian Cardenas is seeing in actual reality for the first time. “I can see you,” Christian told Jeff... read more
13Apr

Pyramid Biosciences Announces TIME Trial™ Program Collaboration with Tempus for Patients with NTRK Fusion Solid Tumors

Pyramid Biosciences, Inc., a clinical-stage biotechnology company developing a portfolio of precision therapies targeting a range of serious diseases, today... read more